Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Shares Issued (2021 - 2025)

InMed Pharmaceuticals' Shares Issued history spans 5 years, with the latest figure at $663671.0 for Q2 2025.

  • For Q2 2025, Shares Issued rose 66367000.0% year-over-year to $663671.0; the TTM value through Jun 2025 reached $5.0 million, up 146.77%, while the annual FY2025 figure was $5.0 million, 3.67% down from the prior year.
  • Shares Issued reached $663671.0 in Q2 2025 per INM's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $12.0 million in Q3 2021 to a low of -$10.7 million in Q2 2023.
  • Average Shares Issued over 5 years is $1.8 million, with a median of $846867.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: plummeted 307.54% in 2023, then skyrocketed 66367000.0% in 2025.
  • A 5-year view of Shares Issued shows it stood at $176.0 in 2021, then surged by 2695346.59% to $4.7 million in 2022, then crashed by 325.13% to -$10.7 million in 2023, then soared by 103.71% to $396153.0 in 2024, then soared by 67.53% to $663671.0 in 2025.
  • Per Business Quant, the three most recent readings for INM's Shares Issued are $663671.0 (Q2 2025), $2.9 million (Q1 2025), and $396153.0 (Q4 2024).